Overview of the HIV/AIDS epidemic, scientific research and government responses in China
- 1 December 2007
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (Suppl 8) , S3-S7
- https://doi.org/10.1097/01.aids.0000304690.24390.c2
Abstract
The unique pattern of the HIV/AIDS epidemic in China--high HIV infection rate among injecting drug users (IDUs) and former plasma donors (FPDs)--but a relatively low overall infection rate in the country provides a window period for taking action. Over the past 10 years, Chinese scientists have conducted several pilot demonstration projects that provided domestic evidence for policy development for controlling AIDS. More recently, the Chinese government has taken bold steps to scale-up HIV testing and counseling, offer free anti-retroviral treatment to AIDS patients, and expand primary prevention measures such as methadone maintenance and needle exchange programs for drug users and condom promotion for sex workers and men who have sex with men. The remarkable achievements in such a short period of time indicate that China is strongly committed to limiting the epidemic and maintaining a low HIV prevalence into the future.Keywords
This publication has 19 references indexed in Scilit:
- Acceptance of and barriers to voluntary HIV counselling and testing among adults in Guizhou province, ChinaAIDS, 2007
- Effectiveness of first eight methadone maintenance treatment clinics in ChinaAIDS, 2007
- A five-city trial of a behavioural intervention to reduce sexually transmitted disease/HIV risk among sex workers in ChinaAIDS, 2007
- The first community-based sexually transmitted disease/HIV intervention trial for female sex workers in ChinaAIDS, 2007
- The development of HIV/AIDS surveillance in ChinaAIDS, 2007
- An evaluation of needle exchange programmes in ChinaAIDS, 2007
- Evolution of China's response to HIV/AIDSThe Lancet, 2007
- HIV Testing in ChinaScience, 2006
- Prevalence of HIV infection among former commercial plasma donors in rural eastern China.Health Policy and Planning, 2001
- HIV-1 infection in commercial plasma donors in ChinaThe Lancet, 1995